Microbiome Sequencing Services Market Research Report – Forecast till 2030

Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User - Forecast till 2030

ID: MRFR/HC/6063-HCR | February 2023 | Region: Global | 160 Pages         

Microbiome Sequencing Services Market Speak to Analyst Request a Free Sample

Microbiome Sequencing Services Market

Microbiome Sequencing Services Market was worth USD 5380.93 million and can capture 18.10% CAGR between 2020–2030.

Segmentation
By Technology Sequencing by Litigation (SBL) Sequencing by Synthesis (SBS) Others
By Application Gastrointestinal Diseases Infectious Diseases Others
Key Players
Companies Profiled   Baseclear B.V.   Clinical Microbiomics A/S   EPIBIOME   Merieux Nutrisciences Corporations   Metabiomics Corp.   Microbiome Insights Inc.   Microbiome Therapeutics LLC.   MR DNA   Rancho Biosciences   Second Genome
Drivers
Market Driving Forces   Rising demand for microbiome research   High investment in next-generation sequencing   Reduction in the cost of next-generation sequencing
Request a Free Sample

Microbiome Sequencing Services Market Overview:


The microbiome sequencing services market is supposed to develop altogether over the gauge period. It is assessed that the microbiome sequencing administrations market is supposed to enrol a CAGR ~ 18.10% during the conjecture time of 2022-2030, with an expected market worth of USD 5380.93 million by 2030. A microbiome is the one of a kind assortment of trillions of microorganisms in and on a singular's body. Microbiome sequencing is a demonstrative strategy wherein millions and billions of DNA strands can be parallelly sequenced.


The microbiome sequencing administrations market is driven by elements, for example, rising interest for microbiome research, high interest in cutting edge sequencing, and decrease in the expense of advanced sequencing.


For example, as indicated by the information distributed by the Wall Street Journal in 2016, adventure financing in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015. Moreover, augmenting utilizations of microbiome sequencing and ascend in the genome planning programs are driving the development of the market.


Then again, the absence of talented specialists, moral and legitimate issues connected with genome sequencing, and exorbitance of microbiome sequencing administrations in specific economies is frustrating the development of microbiome sequencing administrations market to a degree.


Besides, significant organizations in the market are associated with vital coordinated efforts to support their situation on the lookout. For example, in November 2017, Microbiome Therapeutics, LLC sent off the first microbiome modulator. This item is a characteristic mix of prebiotics fabricated to help support and sustain valuable microorganisms in the lower stomach.


Segmentation


The microbiome sequencing services market has been segmented into technology, application, and end user. The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others. The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others. The market, by end user, has been segmented into research and academic institutes, pharmaceutical and biotechnology companies, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The microbiome sequencing services market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European microbiome sequencing services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microbiome sequencing services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The microbiome sequencing services market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Microbiome Sequencing Services Market Share (%), by Region, 2017


Microbiome Sequencing Services Market


Source: World Health Organization (WHO), Institute of Medicine (IOM)


Geographically, the Americas is expected to dominate the global microbiome sequencing services market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology. Furthermore, rising expenses in research and development by healthcare bodies and the government is anticipated to drive the growth of the market in this region.


Europe showed a considerable amount of growth in the global microbiome sequencing services market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the microbiome sequencing services market.


Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. However, less capital investment and awareness regarding healthcare IT are restricting the market growth of this region.


On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, the limited adoption of advanced healthcare facilities and limited access to treatment facilities is also expected to drive the growth of the market in the near future.


Microbiome Sequencing Services Market, by Technology



  • Sequencing by Litigation (SBL)

  • Sequencing by Synthesis (SBS)

  • Short Gun Sequencing

  • Targeted Gene Sequencing

  • RNA Sequencing

  • Others


Microbiome Sequencing Services Market, by Application



  • Gastrointestinal Diseases

  • Infectious Diseases

  • CNS Diseases

  • Oncology

  • Others


Microbiome Sequencing Services Market, by End User



  • Research and Academic Institutes

  • Pharmaceutical and Biotechnology Companies

  • Others


Microbiome Sequencing Services Market, by Region




  • Americas


    • North America

      • US

      • Canada



    • Latin America




  • Europe


    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe




  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific




  • Middle East & Africa

    • Middle East

    • Africa




Microbiome Sequencing Services Market, by Key Players



  • Baseclear B.V.

  • Clinical Microbiomics A/S

  • EPIBIOME

  • Merieux Nutrisciences Corporations

  • Metabiomics Corp.

  • Microbiome Insights Inc.

  • Microbiome Therapeutics, LLC.

  • MR DNA

  • Rancho Biosciences

  • Second Genome

  • Ubiome, Inc.

  • Zymo Research Corp.


Recent Development


In July 2020:


Microba and Synlab inked a consent to send off Microbiome Test in Europe and Latin America. The test estimates bacterial species in the stomach microbiome and computes their metabolic potential corresponding to solid reference ranges. The item send off will bring its entire genome metagenomic sequencing and bioinformatics programming to new business sectors.


Β In January 2019:


Clinical Microbiomics A/S offer full-administration progressed microbiome examination covering the whole work process from separating DNA, sequencing, profiling, and biostatistics connecting the microbiome to important clinical boundaries.Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities

  • Venture Capitalists



Report Scope:

Report Attribute/Metric Details
  Market Size   2030 : 5380.93 Million
  CAGR   18.10% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Application, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporations, Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome Inc., Zymo Research Corp.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising demand for microbiome research
  • High investment in next-generation sequencing
  • Reduction in the cost of next-generation sequencing


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The microbiome sequencing services market was valued at USD 5380.93 million in 2030.

    The microbiome sequencing services market is expected to exhibit a robust 18.10% CAGR over the forecast period from 2020 to 2030

    The rising demand for microbiome research and next-generation sequencing is the major driver for the market.

    The Americas hold the dominant share in the market.

    Leading players in the microbiome sequencing services market include Baseclear, EPIBIOME, Metabiomics, MR DNA, Ubiome, and Zymo Research Corp., among others.